Functional effects of chronic electroconvulsive shock on serotonergic 5-HT(1A) and 5-HT(1B) receptor activity in rat hippocampus and hypothalamus
- PMID: 12363404
- DOI: 10.1016/s0006-8993(02)03193-1
Functional effects of chronic electroconvulsive shock on serotonergic 5-HT(1A) and 5-HT(1B) receptor activity in rat hippocampus and hypothalamus
Abstract
The aims of this work were to determine the influence of chronic electroconvulsive shock (ECS) on presynaptic 5-HT(1A) receptor function, postsynaptic 5-HT(1A) receptor function in hippocampus and hypothalamus, and presynaptic 5-HT(1B) receptor function in hippocampus and hypothalamus. This represents part of an on-going study of the effects of ECS on serotonergic receptor activity in selected brain areas which may be relevant to the effects of electroconvulsive therapy (ECT) in humans. Chronic ECS reduced the ability of the 5-HT(1A) receptor agonist 8-hydroxy-2(di-n-propylamino)tetraline (8-OH-DPAT) (0.2 mg/kg s.c.) to decrease 5-HT levels in hypothalamus as shown by in vivo microdialysis, indicative of a reduction in sensitivity of presynaptic 5-HT(1A) autoreceptors. The ability of the 5-HT(1B) receptor antagonist GR 127935 (5 mg/kg s.c.) to increase 5-HT levels in both hippocampus and hypothalamus was unaffected by chronic ECS. 8-OH-DPAT (0.2 mg/kg s.c.) increased cyclic AMP levels in hippocampus measured by in vivo microdialysis approximately 2-fold. The degree of stimulation of cyclic AMP formation was not altered by chronic ECS. However the cyclic AMP response to forskolin (50 micro M) administered via the microdialysis probe, which was approximately 4-fold of basal in sham-treated rats, was almost completely abolished in ECS-treated rats. Since this indicates that either adenylate cyclase catalytic unit activity or Gs protein activity is reduced in the hippocampus after chronic ECS, the lack of change in 8-OH-DPAT-induced cyclic AMP formation may be taken as possible evidence of an increase in sensitivity of postsynaptic 5-HT(1A) receptors in the hippocampus by chronic ECS. Chronic ECS increased basal plasma levels of corticosterone, ACTH and oxytocin. The ACTH response to s.c. injections of 0.2 mg/kg or 0.5 mg/kg 8-OH-DPAT was reduced by chronic ECS. Postsynaptic 5-HT(1A) receptor activity in the hypothalamus, in contrast to the hippocampus, thus appears to be desensitized after chronic ECS. We conclude that chronic ECS has regionally specific effects on both pre- and post-synaptic 5-HT(1A) receptors, but, in contrast to some antidepressant drugs, does not affect presynaptic 5-HT(1B) receptor activity.
Similar articles
-
Chronic clomipramine alters presynaptic 5-HT(1B) and postsynaptic 5-HT(1A) receptor sensitivity in rat hypothalamus and hippocampus, respectively.Neuropharmacology. 2000 Sep;39(12):2309-17. doi: 10.1016/s0028-3908(00)00077-0. Neuropharmacology. 2000. PMID: 10974314
-
Functional effects of corticosterone on 5-HT(1A) and 5-HT(1B) receptor activity in rat brain: in vivo microdialysis studies.Eur J Pharmacol. 2001 Jan 5;411(1-2):115-122. doi: 10.1016/s0014-2999(00)00911-0. Eur J Pharmacol. 2001. PMID: 11137865
-
The differential effects of food restriction on 5-HT1A and 5-HT1B receptor mediated control of serotonergic transmission in the hippocampus and hypothalamus of rats.Nutr Neurosci. 2003 Jun;6(3):169-75. doi: 10.1080/1028415031000115936. Nutr Neurosci. 2003. PMID: 12793521
-
Selective breeding of 5-HT(1A) receptor-mediated responses: application to emotion and receptor action.Pharmacol Biochem Behav. 2000 Dec;67(4):701-8. doi: 10.1016/s0091-3057(00)00415-9. Pharmacol Biochem Behav. 2000. PMID: 11166060 Review.
-
The role of the dorsal hippocampal serotonergic and cholinergic systems in the modulation of anxiety.Pharmacol Biochem Behav. 2000 May;66(1):65-72. doi: 10.1016/s0091-3057(00)00198-2. Pharmacol Biochem Behav. 2000. PMID: 10837844 Review.
Cited by
-
Non-Invasive Brain Stimulation Effects on Biomarkers of Tryptophan Metabolism: A Scoping Review and Meta-Analysis.Int J Mol Sci. 2022 Aug 26;23(17):9692. doi: 10.3390/ijms23179692. Int J Mol Sci. 2022. PMID: 36077088 Free PMC article.
-
The 5-HT1B receptor - a potential target for antidepressant treatment.Psychopharmacology (Berl). 2018 May;235(5):1317-1334. doi: 10.1007/s00213-018-4872-1. Epub 2018 Mar 15. Psychopharmacology (Berl). 2018. PMID: 29546551 Free PMC article. Review.
-
5-HTR1A and 5-HTR2A genetic polymorphisms and SSRI antidepressant response in depressive Chinese patients.Neuropsychiatr Dis Treat. 2016 Jul 4;12:1623-9. doi: 10.2147/NDT.S93562. eCollection 2016. Neuropsychiatr Dis Treat. 2016. PMID: 27445478 Free PMC article.
-
Lack of modulatory effect of short-term repeated electroconvulsive therapy on platelet vesicular monoamine transporter 2 (VMAT2) in depressed patients.J Neural Transm (Vienna). 2010 Jul;117(7):881-5. doi: 10.1007/s00702-010-0427-2. Epub 2010 Jun 11. J Neural Transm (Vienna). 2010. PMID: 20544232
-
From molecular biology to pharmacogenetics: a review of the literature on antidepressant treatment and suggestions of possible candidate genes.Psychopharmacology (Berl). 2004 Aug;174(4):490-503. doi: 10.1007/s00213-004-1822-x. Epub 2004 Mar 2. Psychopharmacology (Berl). 2004. PMID: 14997279 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources